These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30912765)

  • 1. FoxO3 activation in hypoxic tubules prevents chronic kidney disease.
    Li L; Kang H; Zhang Q; D'Agati VD; Al-Awqati Q; Lin F
    J Clin Invest; 2019 Mar; 129(6):2374-2389. PubMed ID: 30912765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular β-catenin and FoxO3 interactions protect in chronic kidney disease.
    Nlandu-Khodo S; Osaki Y; Scarfe L; Yang H; Phillips-Mignemi M; Tonello J; Saito-Diaz K; Neelisetty S; Ivanova A; Huffstater T; McMahon R; Taketo MM; deCaestecker M; Kasinath B; Harris RC; Lee E; Gewin LS
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32369448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular regulation and function of FoxO3 in chronic kidney disease.
    Lin F
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):439-445. PubMed ID: 32427691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead box O3 (FoxO3) regulates kidney tubular autophagy following urinary tract obstruction.
    Li L; Zviti R; Ha C; Wang ZV; Hill JA; Lin F
    J Biol Chem; 2017 Aug; 292(33):13774-13783. PubMed ID: 28705935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO3 Activation Prevents Cellular Senescence in Emphysema Induced by Cigarette Smoke.
    Jiang H; Xu Y; Jiang Y; Li Y
    COPD; 2023 Dec; 20(1):80-91. PubMed ID: 36656684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling.
    Li ZL; Wang B; Lv LL; Tang TT; Wen Y; Cao JY; Zhu XX; Feng ST; Crowley SD; Liu BC
    Acta Pharmacol Sin; 2021 Dec; 42(12):2106-2119. PubMed ID: 33658705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of an integrative network of microRNAs and transcriptomics changes for acute kidney injury.
    Lee CG; Kim JG; Kim HJ; Kwon HK; Cho IJ; Choi DW; Lee WH; Kim WD; Hwang SJ; Choi S; Kim SG
    Kidney Int; 2014 Nov; 86(5):943-53. PubMed ID: 24759152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAS protein activator-like 2 (RASAL2) initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis.
    Zhang Y; Yang Y; Hu X; Wei B; Shen Q; Shi C; Chen P
    Transl Res; 2024 Jul; 269():14-30. PubMed ID: 38453052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt6 attenuates hypoxia-induced tubular epithelial cell injury via targeting G2/M phase arrest.
    Gao Z; Chen X; Fan Y; Zhu K; Shi M; Ding G
    J Cell Physiol; 2020 Apr; 235(4):3463-3473. PubMed ID: 31603249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Going from acute to chronic kidney injury with FoxO3.
    Gu X; Raman A; Susztak K
    J Clin Invest; 2019 May; 129(6):2192-2194. PubMed ID: 31063992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioinspired carbon monoxide delivery system prevents acute kidney injury and the progression to chronic kidney disease.
    Nagasaki T; Maeda H; Taguchi K; Yanagisawa H; Nishida K; Kobayashi K; Wada N; Noguchi I; Murata R; Sakai H; Kitagishi H; Saruwatari J; Watanabe H; Otagiri M; Maruyama T
    Redox Biol; 2022 Aug; 54():102371. PubMed ID: 35763935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the transition from acute to chronic kidney injury following ischemia/reperfusion.
    Liu J; Kumar S; Dolzhenko E; Alvarado GF; Guo J; Lu C; Chen Y; Li M; Dessing MC; Parvez RK; Cippà PE; Krautzberger AM; Saribekyan G; Smith AD; McMahon AP
    JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
    Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
    Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.
    Baek JH; Zeng R; Weinmann-Menke J; Valerius MT; Wada Y; Ajay AK; Colonna M; Kelley VR
    J Clin Invest; 2015 Aug; 125(8):3198-214. PubMed ID: 26121749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human proximal tubular epithelial cell-derived small extracellular vesicles mediate synchronized tubular ferroptosis in hypoxic kidney injury.
    Wang X; Kim CS; Adams BC; Wilkinson R; Hill MM; Shah AK; Mohamed A; Dutt M; Ng MSY; Ungerer JPJ; Healy HG; Kassianos AJ
    Redox Biol; 2024 Apr; 70():103042. PubMed ID: 38244399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
    Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
    Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.
    Shu S; Zhu J; Liu Z; Tang C; Cai J; Dong Z
    EBioMedicine; 2018 Nov; 37():269-280. PubMed ID: 30314894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition.
    Lok SWY; Yiu WH; Zou Y; Xue R; Li H; Ma J; Chen J; Chan LYY; Lai KN; Tang SCW
    Nephrol Dial Transplant; 2023 Sep; 38(10):2232-2247. PubMed ID: 36914214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis.
    Kong KH; Oh HJ; Lim BJ; Kim M; Han KH; Choi YH; Kwon K; Nam BY; Park KS; Park JT; Han SH; Yoo TH; Lee S; Kim SJ; Kang DH; Choi KB; Eremina V; Quaggin SE; Ryu DR; Kang SW
    Sci Rep; 2017 Sep; 7(1):11351. PubMed ID: 28900259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.